Skip to content
‹ Back to IndustriesHealthcare

Making Bright Ideas Work: The Trade Group Looking Out for the MedTech Community

Perhaps no state is more renowned for medicine than Massachusetts. The Commonwealth is host to leading hospitals, medical centers, and medical device companies that are maturing next generation technologies. But medtech enterprises large and small need representatives to ensure that innovations in the space can thrive. That’s where Brian Johnson comes in. He is…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Perhaps no state is more renowned for medicine than Massachusetts. The Commonwealth is host to leading hospitals, medical centers, and medical device companies that are maturing next generation technologies. But medtech enterprises large and small need representatives to ensure that innovations in the space can thrive.

That’s where Brian Johnson comes in. He is President of the Massachusetts Medical Device Industry Council (MassMEDIC) and on this week’s episode of Making Bright Ideas Work, a Sunrise Labs podcast, he shared insights into his advocacy work.

“We help maintain a healthy environment for medical device innovators,” Johnson said. Medicine is a highly regulated industry so his trade group works with government partners to streamline processes and ensure a healthy ecosystem that fosters innovation.

Whether its pushing for the repeal of the medical device tax or staying atop of Brexit and its complications for medical device companies, MassMEDIC is there looking out for its members and the medtech community as a whole.

“Massachusetts continues to be a robust environment in this space,” he contended, and cited Sunrise Labs as one of the leaders pushing medtech forward. He also works with a number of startups disrupting the industry, and advises that novice CEOs should focus less energy on raising money and more on their plan to go from zero to commercialization.

“You need to think about the entire lifespan of this company as a founder,” Johnson said.

As a former company founder himself, Brian feels passionately about helping other founders. It’s why he’s become a personal champion of MassMEDIC IGNITE, which provides the medtech startup community with training, mentorship, and networking.

“I really love medtech,” Johnson confessed, and said that the innovations advanced by medical device companies are on par with those of the space program.

He is proud and amazed at the medical advances that come out of the Commonwealth. The first surgery with anesthesia was done in Massachusetts and now leading hospitals in the state are performing surgeries using advanced robotics or remote surgeons.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @HealthMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris launches blood-based treatment response monitoring as Q3 revenue rises 27%

Caris Life Sciences completed approximately 61,500 clinical cases in Q3 2026 and raised 2026 revenue guidance to $1.04-$1.05 billion. Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a minimal residual disease assay, is targeted to launch before year-end.

  • 01Caris said higher operating expenses were driven primarily by headcount-related costs, research and development investment and marketing.
  • 02Caris Assure is now available for therapeutic response monitoring, and Caris Confirm, a whole genome, tumor-informed assay for minimal residual disease, is targeted to launch before year-end.
  • 03Caris reaffirms its guidance for clinical therapy selection volume growth of approximately 20%.

Nov 8, 2026

Denials get a queue, underpayments just look like paid claims

Denials get a queue, underpayments just look like paid claims

Underpayments in healthcare revenue cycle operations lack the visibility of denied claims because they don't trigger alerts or queue workflows. Without dedicated ownership and line-level verification against contract terms, paid claims that fall short of their contractual amount pass through undetected.

  • 01Denial workflows activate on rejection events, but underpayments produce no event, leaving paid claims unverified by default.
  • 02The speaker says many provider groups lack line-level contract intelligence to check each paid line against the applicable terms.
  • 03Payment received and payment checked are separate tasks: one verifies acceptance, the other verifies correctness—and the second often has no assigned owner.

Nov 6, 2026

A zero-paid claim line is not automatically an underpayment

A zero-paid claim line is not automatically an underpayment

A zero payment on a claim line isn't automatically an underpayment; contract terms, particularly packaging rules, determine whether zero is correct. Chasing unsupported findings damages credibility with payers and weakens the position of legitimate disputes, so revenue cycle teams must verify the full contract terms and effective dates before treating any payment difference as a finding.

  • 01When a contract packages add-ons into the primary procedure, the add-on line may legitimately show zero payment because it is folded into the primary procedure reimbursement.
  • 02Pursuing payment differences that lack contract support burns credibility with payers and can weaken the team’s position on later disputes, including valid ones.
  • 03Always verify the complete contract terms, fee schedules, carve-outs, amendments, and the specific version in effect on the date of service before treating a payment variance as a recoverable underpayment.

Nov 6, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512